Clinical Trial Update: iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update for an iPSC-based drug repurposing study (iDReAM) in amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Kyoto University | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN